Literature DB >> 21495267

The influence of Nifadin, Niprisan and Niprd/92/001/1-1 (AM-1) on the pharmacokinetics of metronidazole in rats.

M T Bakare-Odunola1, K B Mustapha, M Garba, O O Obodozie, I S Enemali.   

Abstract

The single oral dose pharmacokinetics of metronidazole was studied alone and after co-administration with phytomedicines, Nifadin, Niprisan and Niprd/92/001/1-1 (AM-1), in rats. Plasma metronidazole concentrations were measured using high-performance liquid chromatography method developed earlier in our laboratory. The data were fitted into a WinNonlin standard non-compartmental programme. The co-administration of the herbal medicines with metronidazole produced an increase in the serum concentration of metronidazole at each sampling time. The highest increase of 184% occurring at the time of peak concentration (1 h) was obtained with AM-1, followed by 145% with Niprisan, the least was 131% with Nifadin. Significant increase was also observed in some other parameters, such as area under the serum concentration-time curve (AUC0-24) and maximum serum concentration (Cmax), while the apparent volume of distribution (Vd) and plasma clearance (C1) reduced significantly (P < 0.05). It was concluded that the gastric presence of the herbal medicines impaired the absorption and elimination Niadin alone) of metronidazole in rats significantly (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21495267     DOI: 10.1007/s13318-010-0008-7

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  8 in total

1.  The effect of garlic supplements on the pharmacokinetics of saquinavir.

Authors:  Stephen C Piscitelli; Aaron H Burstein; Nada Welden; Keith D Gallicano; Judith Falloon
Journal:  Clin Infect Dis       Date:  2001-12-05       Impact factor: 9.079

2.  Alteration of oral salivary pharmacokinetics of paracetamol by an investigational anti-malarial phytomedicine, in healthy human volunteers.

Authors:  O Obodozie; K Mustapha; U Inyang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jul-Sep       Impact factor: 2.441

3.  In vivo approach to determine the route of optimal drug absorption in rats.

Authors:  O Lhote; A Decoodt; A Moulin; A Dufour
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991       Impact factor: 2.441

4.  Effect of niprisan on single oral dose pharmacokinetics of paracetamol in rats.

Authors:  B Adzu; M Garba; A Haruna; M Maman; C Wambebe; K Gamaniel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jul-Sep       Impact factor: 2.441

5.  Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

Authors:  K S Lown; D G Bailey; R J Fontana; S K Janardan; C H Adair; L A Fortlage; M B Brown; W Guo; P B Watkins
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 6.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

7.  Interaction between chloroquine sulphate and aqueous extract of Azadirachta indica A. Juss (Meliaceae) in rabbits.

Authors:  Sunday Vitalis Nwafor; Peter Achunike Akah; Charles Obgonnaya Okoli; Adaoma Chinaemerem Onyirioha; Chukwuemeka Sylvesta Nworu
Journal:  Acta Pharm       Date:  2003-12       Impact factor: 2.230

8.  The influence of lamivudine, stavudine and nevirapine on the pharmacokinetics of chlorpropamide in human subjects.

Authors:  M T Bakare-Odunola; I Enemali; M Garba; O O Obodozie; K B Mustapha
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

  8 in total
  1 in total

1.  Effect of NIPRISAN® on CYP3A4 activity in vitro.

Authors:  Bulus Adzu; Collen Masimirembwa; Kudirat Bola Mustapha; Roslyn Thelingwani; Rukaiyatu Abdullahi Kirim; Karniyus Shingu Gamaniel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-01-24       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.